Physician profile
Samir N Bhatt
NPI 1295925972
$322,749.97
in general payments reported to CMS, 2019-2025
43 companies · $56K in 2025
The $56K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $15K · 2021: $38K · 2022: $37K · 2023: $59K · 2024: $68K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $133K · Travel and Lodging: $36K · Food and Beverage: $13K · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $133,196.00 |
| Travel and Lodging | $36,203.98 |
| Food and Beverage | $13,273.24 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $194,272.24 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $44,615.94 | 2020-2025 | Nexletol, Nexlizet |
| Sanofi-Aventis U.S. LLC | $22,868.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $12,580.35 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $12,134.54 | 2019-2025 | Watchman Access System, Emblem Mri S-Icd, Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $10,703.68 | 2019-2023 | Evkeeza |
| Amarin Pharma, INC. | $9,837.10 | 2019-2021 | |
| Abbott Laboratories | $3,647.19 | 2019-2025 | Gallant, Mitraclip, Assurity |
| Abiomed | $1,818.18 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,436.58 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,180.74 | 2020-2025 | Jardiance |
| Philips North America LLC | $986.57 | 2019-2024 | (P84) Igt Devices Systems |
| Biotronik INC. | $814.84 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $690.73 | 2022-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $676.53 | 2019-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $557.95 | 2022-2025 | Verquvo, Winrevair |
| Heartflow, INC. | $477.14 | 2019-2025 | |
| Medtronic, INC. | $445.81 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Asahi Intecc USA, INC. | $429.16 | 2020 | |
| Alnylam Pharmaceuticals INC. | $388.41 | 2023-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals Lp | $291.21 | 2019-2024 | Farxiga, Wainua |
| Getinge USA Sales, LLC | $277.53 | 2020-2022 | |
| Edwards Lifesciences Corporation | $277.11 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $172.10 | 2020-2024 | Eliquis, Camzyos |
| Pfizer INC. | $139.35 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $127.05 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Madrigal Pharmaceuticals | $115.37 | 2025 | Rezdiffra |
| Atricure, INC. | $106.80 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.25 | 2019-2025 | Lifevest |
| Janssen Scientific Affairs, LLC | $92.70 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $79.08 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $67.10 | 2025 | |
| Biosense Webster, INC. | $64.91 | 2019 | |
| Acist Medical Systems, INC. | $56.00 | 2021 | |
| Teleflex LLC | $37.74 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $33.27 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $32.56 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $28.95 | 2022 | |
| United Therapeutics Corporation | $21.31 | 2024 | Tyvaso |
| Mannkind Corporation | $19.92 | 2025 | |
| Chiesi USA, INC. | $18.66 | 2023 | Kengreal |
| Scpharmaceuticals INC. | $18.64 | 2024 | |
| Braemar Manufacturing, LLC | $17.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.